A phase I study of HYB2055 in patients (pts) with advanced solid malignancies

被引：0
|
作者：
Hwang, JJ
Park, S
Amin, A
Martin, RR
Sullivan, T
Burns, T
Agrawal, S
Waxdal, MJ
Malik, S
Marshall, JL
机构：
[1] Georgetown Univ, Med Ctr, Washington, DC 20057 USA
[2] Hybridon Inc, Cambridge, MA USA
[3] Fast Syst, Gaithersburg, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3111
引用
收藏
页码：222S / 222S
页数：1
相关论文
共 50 条
  • [31] A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies
    Rowinsky, Eric K.
    Beeram, Muralidhar
    Hammond, Lisa A.
    Schwartz, Garry
    De Bono, Johann
    Forouzesh, Baharam
    Chu, Quincy
    Latz, Jane E.
    Hong, Shengyan
    John, William
    Nguyen, Binh
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 532 - 539
  • [32] Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies
    Monica Mita
    Alain Mita
    John Sarantopoulos
    Chris H. Takimoto
    Eric K. Rowinsky
    Ofelia Romero
    Patrizia Angiuli
    Cecilia Allievi
    Amy Eisenfeld
    Claire F. Verschraegen
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 287 - 295
  • [33] Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies
    Mita, Monica
    Mita, Alain
    Sarantopoulos, John
    Takimoto, Chris H.
    Rowinsky, Eric K.
    Romero, Ofelia
    Angiuli, Patrizia
    Allievi, Cecilia
    Eisenfeld, Amy
    Verschraegen, Claire F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 287 - 295
  • [34] Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
    Yu Sunakawa
    Keishiro Takahashi
    Osamu Kawaguchi
    Nobuyuki Yamamoto
    Investigational New Drugs, 2022, 40 : 1032 - 1041
  • [35] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    Sayar, H.
    Shen, Z.
    Lee, S. J.
    Royce, M.
    Rabinowitz, I.
    Lee, F.
    Smith, H.
    Eberhardt, S.
    Maestas, A.
    Lu, H.
    Verschraegen, C.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 153 - 158
  • [36] A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies
    Petit, T
    Aylesworth, C
    Burris, H
    Ravdin, P
    Rodriguez, G
    Smith, L
    Peacock, N
    Smetzer, L
    Bellet, R
    Von Hoff, DD
    Rowinsky, EK
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 223 - 229
  • [37] Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies
    Chu, Quincy S. C.
    Schwartz, Garry
    de Bono, Johann
    Smith, Deborah A.
    Koch, Kevin M.
    Versola, Melissa J.
    Pandite, Lini
    Arya, Nikita
    Curtright, Jan
    Fleming, Ronald A.
    Ho, Peter T. C.
    Rowinsky, Eric K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3753 - 3758
  • [38] Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
    Sunakawa, Yu
    Takahashi, Keishiro
    Kawaguchi, Osamu
    Yamamoto, Nobuyuki
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) : 1032 - 1041
  • [39] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    H. Sayar
    Z. Shen
    S. J. Lee
    M. Royce
    I. Rabinowitz
    F. Lee
    H. Smith
    S. Eberhardt
    A. Maestas
    H. Lu
    C. Verschraegen
    Investigational New Drugs, 2009, 27 : 153 - 158
  • [40] A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies
    Plummer, Ruth
    Woll, Penella
    Fyfe, David
    Boddy, Alan V.
    Griffin, Melanie
    Hewitt, Paula
    Carmichael, James
    Namouni, Fouad
    Cohen, Marvin
    Verrill, Mark
    CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8288 - 8294
12345